Yehia Baligh R, Herati Ramin S, Fleishman John A, Gallant Joel E, Agwu Allison L, Berry Stephen A, Korthuis P Todd, Moore Richard D, Metlay Joshua P, Gebo Kelly A
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
PLoS One. 2014 Jul 17;9(7):e102766. doi: 10.1371/journal.pone.0102766. eCollection 2014.
Guidelines recommend hepatitis C virus (HCV) screening for all people living with HIV (PLWH). Understanding HCV testing practices may improve compliance with guidelines and can help identify areas for future intervention.
We evaluated HCV screening and unnecessary repeat HCV testing in 8,590 PLWH initiating care at 12 U.S. HIV clinics between 2006 and 2010, with follow-up through 2011. Multivariable logistic regression examined the association between patient factors and the outcomes: HCV screening (≥1 HCV antibody tests during the study period) and unnecessary repeat HCV testing (≥1 HCV antibody tests in patients with a prior positive test result).
Overall, 82% of patients were screened for HCV, 18% of those screened were HCV antibody-positive, and 40% of HCV antibody-positive patients had unnecessary repeat HCV testing. The likelihood of being screened for HCV increased as the number of outpatient visits rose (adjusted odds ratio 1.02, 95% confidence interval 1.01-1.03). Compared to men who have sex with men (MSM), patients with injection drug use (IDU) were less likely to be screened for HCV (0.63, 0.52-0.78); while individuals with Medicaid were more likely to be screened than those with private insurance (1.30, 1.04-1.62). Patients with heterosexual (1.78, 1.20-2.65) and IDU (1.58, 1.06-2.34) risk compared to MSM, and those with higher numbers of outpatient (1.03, 1.01-1.04) and inpatient (1.09, 1.01-1.19) visits were at greatest risk of unnecessary HCV testing.
Additional efforts to improve compliance with HCV testing guidelines are needed. Leveraging health information technology may increase HCV screening and reduce unnecessary testing.
指南建议对所有感染人类免疫缺陷病毒(HIV)的人(PLWH)进行丙型肝炎病毒(HCV)筛查。了解HCV检测实践可能会提高对指南的依从性,并有助于确定未来干预的领域。
我们评估了2006年至2010年间在美国12家HIV诊所开始接受治疗的8590名PLWH的HCV筛查和不必要的重复HCV检测情况,并随访至2011年。多变量逻辑回归分析了患者因素与以下结果之间的关联:HCV筛查(研究期间≥1次HCV抗体检测)和不必要的重复HCV检测(先前检测结果为阳性的患者中≥1次HCV抗体检测)。
总体而言,82%的患者接受了HCV筛查,其中18%的筛查者HCV抗体呈阳性,40%的HCV抗体阳性患者进行了不必要的重复HCV检测。随着门诊就诊次数的增加,接受HCV筛查的可能性也增加(调整后的优势比为1.02,95%置信区间为1.01-1.03)。与男男性行为者(MSM)相比,注射吸毒者(IDU)接受HCV筛查的可能性较小(0.63,0.52-0.78);而有医疗补助的个体比有私人保险的个体更有可能接受筛查(1.30,1.04-1.62)。与MSM相比,有异性性行为风险(1.78,1.20-2.65)和IDU风险(1.58,1.06-2.34)的患者,以及门诊就诊次数较多(1.03,1.01-1.04)和住院就诊次数较多(1.09,1.01-1.19)的患者进行不必要HCV检测的风险最大。
需要做出更多努力来提高对HCV检测指南的依从性。利用健康信息技术可能会增加HCV筛查并减少不必要的检测。